Posters
« Back
Automated in-gel digestion on a commercial autosampler directly coupled to nanoLC-MS/MS
EP23318
Automated in-gel digestion on a commercial autosampler directly coupled to nanoLC-MS/MS
Submitted on 28 Aug 2015

Achermann François, Bolliger Reto, Buchs Natasha, Doiron Nicholas, Lagache Braga Sophie, Heller Manfred, Boehm Guenter
University of Bern, Department of Clinical Research, Proteomics & Mass Spectrometry Core Facility, Bern, Switzerland : CTC Analytics AG, Zwingen, Switzerland
This poster was presented at ASMS 2015
Poster Views: 1,418
View poster »
Poster Abstract
Methods
We have adapted a manual in-gel digestion protocol, including reduction, alkylation and acid-labile detergent assisted trypsin digestion of proteins, to be performed on a PAL RTC liquid handling – autosampler system (CTC Analytics AG, Switzerland). The system is equipped with park stations for a syringe tool and samples/reagents, a cooled tray stack, an evaporation tool, a heatable incubator with orbital shaking capability, a vortex mixer, a syringe wash station, a centrifuge, and a LC injection valve. The current PAL RTC setup treats batches of 6 gel samples within 7 hours. Peptide extracts in HPLC vials are transferred to a nanoLC-orbitrap XL mass spectrometer (Thermo Scientific, Germany) or can directly be injected by the PAL system. Proteins were identified and quantified with MaxQuant software.

Preliminary data
A 12-protein molecular weight standard (Bio-Rad) was separated over the entire width of a 12.5% SDS-PAGE at two concentrations corresponding to 1ng or 5ng of each protein standard present in vertical slices of 1.5mm width cut from the gel. Four batches, including three slices of each protein concentration, were processed by an experienced human operator or on the PAL RTC system during four consecutive days. Protein yields were determined by identification and quantification with MaxQuant software. The low molecular weight proteins (Mr <20 kDa) were not consistently identified from the 1ng samples with both procedures. This is a known problem with the gel-LC-MS/MS approach. Keratin contaminations were very similar with both procedures and protein concentrations, indicating that keratin proteins were introduced into the samples before the in-gel digestion process. One-way Anova test was used to compare MaxQuant derived non-normalized protein intensities of batches and procedures with Tukey's honestly significant difference criterion to evaluate statistical significance (alpha = 0.05). No statistically significant differences in protein yield between batches and between procedures were found. The average coefficients of variation of the 12 standard proteins were 19.4% and 11.8% at 1ng protein, and 5.8% and 6.5% at 5ng for the manual and the automated procedure, respectively. These results indicate that the PAL RTC automated in-gel digestion protocol performs as well as an experienced human operator, with potentially a better reproducibility achieved on the PAL system when dealing with low protein concentrations. The next step is the direct coupling of the PAL system to the nanoLC-MS/MS system, which will enable to operating on a 24/24 hours, 7/7 days schedule.
Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Strategies for High-Titer Protein Expression Using the ExpiCHO and Expi293 Transient Expression Systems
Chao Yan Liu, Jian Liu, Wanhua Yan, Kyle Williston, Katy Irvin, Henry Chou, Jonathan Zmuda

A Chemically-Defined Baculovirus-Based Expression System for Enhanced Protein Production in Sf9 Cells
Maya Yovcheva, Sara Barnes, Kenneth Thompson, Melissa Cross, Katy Irvin, Mintu Desai, Natasha Lucki, Henry Chiou, Jonathan Zmuda

NEW INSULAR RED PROPOLIS FROM COLOMBIA: BOTANICAL ORIGIN, BIOLOGICAL AND CHEMICAL MARKERS
Salamanca Grosso, G.; Osorio Tangafarife, M.P.

PROPIEDADES FISICOQUIMICAS DE ALMIDONES DE YUCA MODIFICADOS MEDIANTE OXIDACION CON OZONO
Andrea Saavedra; Guillermo Salamanca Grosso; Izabel Cristina Moraes F.

The EurOPDX EDIReX project: towards a European Research Infrastructure on patient-derived cancer models
E. Vinolo 1, J.P. Morris 1, D.G. Alférez 2, J. Arribas 3,4,5, C. Bernadó 3,4,5, A. Bertotti 6, A. Bruna 7, A.T. Byrne 8, C. Caldas 7, R.B. Clarke 2, N. Conte 9, R. Corsi 10, S. Corso 6, M. Crespo 3, A. Dahmani 11, V. Dangles-Marie 11, D. Decaudin 11, Z. Dudová 12, A. Fiori 6, S. Giordano 6, M. Hauptsmann 13, M. Hidalgo 14, C. Isella 6, S. de Jong 15, J. Jonkers 13, A. Křenek 12, O. Krijgsman 13, D. Kouřil 12, J.C. Lacal 14, L. Lanfrancone 16, E. Leucci 17, G.M. Mælandsmo 18, E. Marangoni 11, J. Mason 9, M.Th. Mayrhofer 19, A. Mazzocca 6, T.S. Meehan 9, E. Montaudon 11, F. Nem